Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
JAMA Cardiol
.
2023 Oct 1;8(10):978.
doi: 10.1001/jamacardio.2023.3357.
Authors
Sharlene M Day
1
2
,
James E Udelson
3
4
,
Robert O Bonow
5
6
Affiliations
1
University of Pennsylvania, Philadelphia.
2
Associate Editor for Translational Science, JAMA Cardiology.
3
Division of Cardiology, CardioVascular Center, Tufts Medical Center, Boston, Massachusetts.
4
Associate Editor, JAMA Cardiology.
5
Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
6
Editor, JAMA Cardiology.
PMID:
37639276
DOI:
10.1001/jamacardio.2023.3357
No abstract available